These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Federal involvement in the care of patients with end-stage renal disease: the relationship to the nation's health properties. Dirks HM Transplant Proc; 1973 Jun; 5(2):1047-50. PubMed ID: 4579037 [No Abstract] [Full Text] [Related]
3. Better care aim of dialysis network. Cohodes A Hospitals; 1975 Feb; 49(4):44-8. PubMed ID: 1089592 [No Abstract] [Full Text] [Related]
4. The federal governments's role in management of end-stage renal disease. Burton BT Kidney Int Suppl; 1978 Jun; (8):S61-4. PubMed ID: 357816 [TBL] [Abstract][Full Text] [Related]
6. The dollar benefits of biomedical research: a cost analysis. Fudenberg HH J Lab Clin Med; 1972 Mar; 79(3):353-63. PubMed ID: 4551447 [No Abstract] [Full Text] [Related]
7. The political history of the artificial heart. Strauss MJ N Engl J Med; 1984 Feb; 310(5):332-6. PubMed ID: 6361569 [No Abstract] [Full Text] [Related]
8. National priorities in the artificial kidney program. Burton BT Biomater Med Devices Artif Organs; 1974; 2(4):311-9. PubMed ID: 4618486 [No Abstract] [Full Text] [Related]
18. Secrets of the artificial heart business. Anderson I New Sci; 1984 Dec; 104(1433):7. PubMed ID: 11655657 [No Abstract] [Full Text] [Related]
19. A policy for biomedical research. Report of an Ad Hoc Committee of the Council of Academic Societies of the Association of American Medical Colleges. J Med Educ; 1971 Aug; 46(8):689-743. PubMed ID: 4997950 [No Abstract] [Full Text] [Related]
20. Application of cost-benefit analysis to health systems technology. Klarman HE J Occup Med; 1974 Mar; 16(3):172-86. PubMed ID: 4593983 [No Abstract] [Full Text] [Related] [Next] [New Search]